These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20629628)

  • 21. Identification of protein binding partners of small molecules using label-free methods.
    Saxena C
    Expert Opin Drug Discov; 2016 Oct; 11(10):1017-25. PubMed ID: 27554241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application.
    Ren YS; Li HL; Piao XH; Yang ZY; Wang SM; Ge YW
    Biochem Pharmacol; 2021 Dec; 194():114798. PubMed ID: 34678227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target identification for biologically active small molecules using chemical biology approaches.
    Lee H; Lee JW
    Arch Pharm Res; 2016 Sep; 39(9):1193-201. PubMed ID: 27387321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biased and unbiased strategies to identify biologically active small molecules.
    Abet V; Mariani A; Truscott FR; Britton S; Rodriguez R
    Bioorg Med Chem; 2014 Aug; 22(16):4474-89. PubMed ID: 24811300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small molecule chemical probes of microRNA function.
    Velagapudi SP; Vummidi BR; Disney MD
    Curr Opin Chem Biol; 2015 Feb; 24():97-103. PubMed ID: 25500006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecule probes of cellular pathways and networks.
    Castoreno AB; Eggert US
    ACS Chem Biol; 2011 Jan; 6(1):86-94. PubMed ID: 21087032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.
    Pasquer QTL; Tsakoumagkos IA; Hoogendoorn S
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in discovering small molecules to probe protein function in a systems context.
    Doyle SK; Pop MS; Evans HL; Koehler AN
    Curr Opin Chem Biol; 2016 Feb; 30():28-36. PubMed ID: 26615565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of a Novel Affinity Labeling Method for Target Identification of Bioactive Small Molecules].
    Yamaguchi T
    Yakugaku Zasshi; 2019; 139(12):1513-1521. PubMed ID: 31787638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting RNA structures in diseases with small molecules.
    Shao Y; Zhang QC
    Essays Biochem; 2020 Dec; 64(6):955-966. PubMed ID: 33078198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical strategies for small-molecule probe development in chemical biology.
    Hempel JE; Hong CC
    Methods Mol Biol; 2015; 1263():209-23. PubMed ID: 25618348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand and Target Discovery by Fragment-Based Screening in Human Cells.
    Parker CG; Galmozzi A; Wang Y; Correia BE; Sasaki K; Joslyn CM; Kim AS; Cavallaro CL; Lawrence RM; Johnson SR; Narvaiza I; Saez E; Cravatt BF
    Cell; 2017 Jan; 168(3):527-541.e29. PubMed ID: 28111073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule probes of protein aggregation.
    Young LM; Ashcroft AE; Radford SE
    Curr Opin Chem Biol; 2017 Aug; 39():90-99. PubMed ID: 28649012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shaping the interaction landscape of bioactive molecules.
    Gfeller D; Michielin O; Zoete V
    Bioinformatics; 2013 Dec; 29(23):3073-9. PubMed ID: 24048355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics.
    Lum KM; Sato Y; Beyer BA; Plaisted WC; Anglin JL; Lairson LL; Cravatt BF
    ACS Chem Biol; 2017 Oct; 12(10):2671-2681. PubMed ID: 28930429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of Strategic Small-Scale Targeted Screening.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Aug; 14(6):329-32. PubMed ID: 27341343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Strength and specificity of the CMBA screening platform for bioactive molecules discovery].
    Barette C; Soleilhac E; Charavay C; Cochet C; Fauvarque MO
    Med Sci (Paris); 2015 Apr; 31(4):423-31. PubMed ID: 25958761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
    Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
    Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target identification and mechanism of action in chemical biology and drug discovery.
    Schenone M; Dančík V; Wagner BK; Clemons PA
    Nat Chem Biol; 2013 Apr; 9(4):232-40. PubMed ID: 23508189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.